Waters Corporation

NYSE:WAT

Sector

🧪 Materials

Industries

🔬 Chemicals & Advanced Materials

📊 Big Data

📈 Financial Reports

🩺 Medical Instruments

🔍 Research & Consulting

Location

United States

Market Cap

USD 21.12 B

Share Price

USD 352.41

Avg Daily Volume

540,285

Change (1 day)

-0.70%

Change (1 year)

23.02%

Change (YTD)

-5.01%

Waters Corporation Total Assets for the year ending December 31, 2024: USD 4.55 B

Waters Corporation Total Assets is USD 4.55 B for the year ending December 31, 2024, a -1.58% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

Waters Corporation Total Assets for the year ending December 31, 2023 was USD 4.63 B, a 41.00% change year over year.
Waters Corporation Total Assets for the year ending December 31, 2022 was USD 3.28 B, a 6.03% change year over year.
Waters Corporation Total Assets for the year ending December 31, 2021 was USD 3.09 B, a 8.98% change year over year.
Waters Corporation Total Assets for the year ending December 31, 2020 was USD 2.84 B, a 11.06% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Total Assets	Accounts Payable	Short-Term Debt	Long-Term Debt

NYSE: WAT

Waters Corporation

CEO	Dr. Udit Batra Ph.D.
IPO Date	Nov. 17, 1995
Location	United States
Headquarters	34 Maple Street
Employees	7,600
Sector	🧪 Materials
Industries Chemicals & Advanced Materials 📊 Big Data 📈 Financial Reports 🩺 Medical Instruments 🔍 Research & Consulting

Description

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.